Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong Buy
2026-02-04 02:43:16 ET
Intro
Achieve Life Sciences ( ACHV ) is a pre-commercial, late-stage pharmaceutical company that develops a smoking and vaping cessation therapy. It currently has no sales-generating business, as it is awaiting the FDA’s decision on whether its drug candidate Cytisinicline will be given the green light in about four months in June. If approved for smoking cessation later this year, it would be the first of its kind since 2006 , i.e., exactly 20 years....
Read the full article on Seeking Alpha
For further details see:
Achieve Life Sciences: Could Be The Best 'Tobacco' Stock For 2026 - Strong BuyNASDAQ: ACHV
ACHV Trading
2.24% G/L:
$4.345 Last:
185,386 Volume:
$4.38 Open:



